Typicality: | 0.550 |
Saliency: | 0.456 |
in canada | 12 | location |
from the year | 10 | temporal |
by the fda | 5 | other |
drug → be approved for → marketing | 76 |
drug → be approved for → the market | 8 |
drug → be approved for → market | 8 |
negative | neutral | positive |
0.120 | 0.674 | 0.206 |
Raw frequency | 92 |
Normalized frequency | 0.456 |
Modifier score | 0.825 |
Perplexity | 146.318 |